Company Filing History:
Years Active: 2012
Title: Francesco Valgimigli: Innovator in Biosensor Technology
Introduction
Francesco Valgimigli is a notable inventor based in Florence, Italy. He has made significant contributions to the field of biosensor technology, particularly in the measurement and control of analytes in biological fluids. His innovative approach has the potential to enhance diagnostic capabilities in medical applications.
Latest Patents
Valgimigli holds a patent for a "Portable device for the measurement and control of analytes in biological fluids." This device is equipped with a biosensor that measures various biological fluids, including glucose. It features electrolytic cells with multiple electrodes and operates with a polarization voltage ranging from a few millivolts to 100 millivolts. The device also measures fluid temperature at the outlet of the electrolytic cell in high resolution, allowing for precise thermal compensation of electrochemical measurements. Additionally, it offers optimized correction for both systematic and random errors, enabling more accurate sensor calibration. The device operates with lower polarization voltages, reducing electrode wear and susceptibility to electrochemical interferences.
Career Highlights
Francesco Valgimigli is associated with A. Menarini Industrie Farmaceutiche Riunite S.r.l., where he applies his expertise in developing innovative medical devices. His work focuses on improving the accuracy and efficiency of biosensors, contributing to advancements in healthcare technology.
Collaborations
Valgimigli has collaborated with notable professionals in his field, including Giorgio Dall'Oglio and Giorgio Dall'oglio. These collaborations have fostered a productive environment for innovation and development in biosensor technology.
Conclusion
Francesco Valgimigli's contributions to biosensor technology exemplify the impact of innovation in healthcare. His patented device represents a significant advancement in the measurement and control of biological fluids, promising to enhance diagnostic accuracy and patient care.